247,012 Shares in Kenvue Inc. $KVUE Bought by Sanctuary Advisors LLC

Key Points

• Sanctuary Advisors LLC bought 247,012 Kenvue shares worth approximately $4.72 million during the second quarter. Institutional investors collectively own 97.64% of the company.
• Analysts remain cautious, with a consensus “Hold” rating from MarketBeat and an average price target of $19.27. Kenvue recently reported quarterly EPS of $0.31, slightly below estimates, while revenue rose 3% year over year to $3.96 billion.
• Kenvue’s shares opened at $19.41, and the company declared a quarterly dividend of $0.21, equivalent to an annualized yield of approximately 4.3%.

Sanctuary Advisors LLC purchased a new stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 247,012 shares of the company's stock, valued at approximately $4,720,000.

A number of other institutional investors have also bought and sold shares of the company. Johnson Financial Group Inc. bought a new stake in shares of Kenvue during the 2nd quarter valued at about $26,000. CoreCap Advisors LLC grew its stake in Kenvue by 64.9% during the second quarter. CoreCap Advisors LLC now owns 1,502 shares of the company's stock worth $29,000 after purchasing an additional 591 shares during the period. Elyxium Wealth LLC bought a new stake in Kenvue in the fourth quarter worth approximately $26,000. Physician Wealth Advisors Inc. increased its holdings in Kenvue by 67.5% in the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company's stock worth $26,000 after purchasing an additional 618 shares in the last quarter. Finally, MV Capital Management Inc. acquired a new position in Kenvue in the fourth quarter valued at approximately $28,000. Institutional investors own 97.64% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. Barclays increased their price target on Kenvue from $18.00 to $19.00 and gave the stock an "equal weight" rating in a report on Tuesday, July 21st. UBS Group lowered their price objective on shares of Kenvue from $20.00 to $19.00 and set a "neutral" rating for the company in a research note on Tuesday, August 11th. Zacks Research downgraded shares of Kenvue from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, July 7th. Weiss Ratings raised shares of Kenvue from a "hold (c-)" rating to a "hold (c)" rating in a research note on Monday, June 15th. Finally, Wall Street Zen cut shares of Kenvue from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. Three equities research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $19.27.

Kenvue Stock Up 1.8%

Shares of NYSE:KVUE opened at $19.41 on Tuesday. The business's 50 day simple moving average is $19.08 and its two-hundred day simple moving average is $18.21. The firm has a market cap of $37.27 billion, a P/E ratio of 22.30, a PEG ratio of 1.36 and a beta of 0.47. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.71 and a current ratio of 1.01. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $21.63.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.31 earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.01). Kenvue had a return on equity of 21.22% and a net margin of 10.76%.The business had revenue of $3.96 billion for the quarter, compared to analyst estimates of $3.97 billion. During the same quarter in the previous year, the company posted $0.29 EPS. The business's quarterly revenue was up 3.0% on a year-over-year basis. As a group, research analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, August 26th. Stockholders of record on Wednesday, August 12th will be paid a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.3%. The ex-dividend date is Wednesday, August 12th. This is a boost from Kenvue's previous quarterly dividend of $0.21. Kenvue's dividend payout ratio (DPR) is presently 96.55%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source